Golub Capital Backs Latest Sagard Acquisition

Golub Capital Backs Latest Sagard Acquisition

Golub Capital was the Sole Lead Arranger and Sole Bookrunner on a $95 million financing and an equity co-investment in connection with the acquisition of IntegraMed America by Sagard Capital Partners.

“It was a pleasure working with the Golub Capital team,” said Michael Braner, Partner at Sagard. “Golub Capital distinguished itself to lead the financing on several fronts including speed of execution, certainty, and flexibility. The team quickly appreciated and understood the intricacies of the business model and was able to think creatively to provide the necessary flexibility to enable IntegraMed to execute their growth strategy.”

IntegraMed develops, markets and manages specialty outpatient healthcare facilities, with a current focus on the fertility market through Attain Fertility Centers and the vein care markets through Vein Clinics of America.

  • Attain Fertility Centers is the nation’s largest fertility center network, with 15 company-managed partner centers and 20 affiliate centers, comprising over 130 locations across 34 states and the District of Columbia. Nearly one of every four IVF procedures in the U.S. is performed in an Attain Fertility Centers network practice (www.attainfertility.com).
  • Vein Clinics of America is the leading provider of specialty vein care services in the U.S. The IntegraMed Vein Clinic network operates 50 centers across 14 states, principally in the Midwest and Southeast (www.veinclinics.com).

IntegraMed supports its provider networks with clinical and business information systems, marketing and sales, facilities and operations management, finance and accounting, human resources, legal, risk management, quality assurance, and fertility treatment financing programs. IntegraMed is based in Purchase, NY (www.integramed.com).

Golub offers buy-and-hold products ranging from $10 million to $75 million and includes one-loan financings, senior, 2nd lien and subordinated debt, preferred stock and co-investment equity. The firm also underwrites and syndicates first lien loans up to $250 million. Golub Capital will hold up to $150 million per transaction. Industries of interest include consumer products, business and consumer services, defense, manufacturing, value-added distribution, media, healthcare services and restaurants. In addition to its New York headquarters, Golub also has offices in Atlanta, GA; and Chicago, IL (www.golubcapital.com).

“We are excited to support Sagard’s acquisition of IntegraMed,” said Spyro Alexopoulos, Managing Director at Golub Capital. “IntegraMed is an established market leader in the fertility and vein care markets that provides its physician practices and clinics a compelling value proposition. This represents our first transaction with Sagard. We were very impressed with their thoughtful approach to the business and have great confidence that they will deliver meaningful incremental value to IntegraMed under their ownership.”

© 2012 PEPD • Private Equity’s Leading News Magazine • 9-21-12

To search in site, type your keyword and hit enter